Skip to main content
Explore URMC


URMC / Pharmacy / Residency Program / PGY2 Programs / PGY2 Oncology

PGY2 Oncology Pharmacy Residency

About the Program

The PGY2 Oncology pharmacy residency at the University of Rochester Medical Center is a 12-month, full-time curriculum that provides the essential elements needed to shape a successful pharmacy specialist. This intensive training involves activities in a wide variety of practice settings:

  • Rounding with multi-disciplinary malignant hematology, medical oncology, and blood/marrow transplant teams
  • Providing ambulatory pharmacy services to both solid and liquid tumor patients in the outpatient Wilmot Cancer Institute clinics
  • Participating in the oral chemotherapy program by providing patient education, clinical follow-up and drug information services
  • Applying appropriate sterile compounding technique for chemotherapy preparation
  • Numerous opportunities for precepting, teaching, and counseling patients, students, residents, pharmacists, and other health care professionals as an integral part of the health care team



The PGY2 Oncology Pharmacy Residency is accredited by the American Society of Health System Pharmacists (ASHP). Its goals, objectives, and evaluation procedures are consistent with the goals and objectives established by ASHP.

Purpose Statement

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification.

This PGY2 advanced pharmacy practice residency program in oncology is intended to develop the knowledge, skills and abilities of a qualified pharmacist that are necessary to be an expert clinical pharmacy practitioner in oncology.  It is intended that a graduate of this program will be fully qualified to develop and sustain an independent and successful clinical pharmacy practice in any oncology setting.


Rotation Schedule

The schedule for the residency year is tailored to meet the needs and interests of the individual resident and is outlined below.

Additional Opportunities and Research

Residents will also have opportunities to develop teaching skills by providing presentations to both the pharmacy staff as well as the faculty, residents, and students in other health care professions. Completion of a research project related to oncology pharmacy is required and the results are to be presented at the Hematology Oncology Pharmacy Association (HOPA) annual conference.

Adam Melaragno, PharmD, BCOP
PGY2 Oncology Residency Director
Clinical Pharmacist, Blood and Marrow Transplant
Wilmot Cancer Institute
University of Rochester Medical Center
601 Elmwood Ave, Box 638
Rochester, NY 14642
Phone: 585-275-6368